Vanguard Group’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $269M | Sell |
|
|||||
|
2025
Q1 | $245M | Sell |
|
|||||
|
2024
Q4 | $409M | Buy |
|
|||||
|
2024
Q3 | $644M | Buy |
|
|||||
|
2024
Q2 | $535M | Buy |
|
|||||
|
2024
Q1 | $638M | Buy |
|
|||||
|
2023
Q4 | $100M | Buy |
|
|||||
|
2023
Q3 | $58.5M | Buy |
|
|||||
|
2023
Q2 | $82.9M | Buy |
|
|||||
|
2023
Q1 | $67.6M | Buy |
|
|||||
|
2022
Q4 | $31.3M | Sell |
|
|||||
|
2022
Q3 | $9.06M | Hold |
|
|||||
|
2022
Q2 | $9.63M | Sell |
|
|||||
|
2022
Q1 | $11M | Buy |
|
|||||
|
2021
Q4 | $15.6M | Buy |
|
|||||
|
2021
Q3 | $21.1M | Buy |
|
|||||
|
2021
Q2 | $19.7M | Buy |
|
|||||
|
2021
Q1 | $20.5M | Sell |
|
|||||
|
2020
Q4 | $19.1M | Buy |
|
|||||
|
2020
Q3 | $19.3M | Sell |
|
|||||
|
2020
Q2 | $24.5M | Buy |
|
|||||
|
2020
Q1 | $15.7M | Buy |
|
|||||
|
2019
Q4 | $25.6M | Buy |
|
|||||
|
2019
Q3 | $21.6M | Sell |
|
|||||
|
2019
Q2 | $30.7M | Buy |
|
|||||
|
2019
Q1 | $30.9M | Buy |
|
|||||
|
2018
Q4 | $19.8M | Sell |
|
|||||
|
2018
Q3 | $50.1M | Buy |
|
|||||
|
2018
Q2 | $22.5M | Buy |
|
|||||
|
2018
Q1 | $6.61M | Buy |
|
|||||
|
2017
Q4 | $4M | Buy |
|
|||||
|
2017
Q3 | $647K | Buy |
|
|||||
|
2017
Q2 | $357K | Hold |
|
|||||
|
2017
Q1 | $483K | Buy |
|
|||||
|
2016
Q4 | $322K | Buy |
|
|||||
|
2016
Q3 | $313K | Buy |
|
|||||
|
2016
Q2 | $259K | Buy |
|
|||||
|
2016
Q1 | $29K | Buy |
|
|||||
|
2015
Q4 | $64K | Buy |
|
|||||
|
2015
Q3 | $106K | Hold |
|
|||||
|
2015
Q2 | $130K | Buy |
|